Emerging studies have indicated that hexadecanedioate may impact mitochondrial function and contribute to mitochondrial dysfunction, which is associated with oxidative stress through ROS/GSH/GPX4 pathway, inflammatory responses, and endothelial dysfunction (Menni et al., 2017), (Peoples et al., 2019). The gene discussed is GPX4; the disease is endothelial dysfunction.